NADIXA

This brand name is authorized in Austria, Mexico, Spain, Turkey.

Active ingredients

The drug NADIXA contains one active pharmaceutical ingredient (API):

1
UNII 6CL9Y5YZEQ - NADIFLOXACIN
 
Read more about Nadifloxacin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D10AF Antiinfectives for treatment of acne D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use
Discover more medicines within D10AF

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
ES Centro de información online de medicamentos de la AEMPS 64291
MX Comisión Federal para la Protección contra Riesgos Sanitarios 307M99
TR İlaç ve Tıbbi Cihaz Kurumu 8699587352804

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈